Dual GIPR and GLP ‐ 1R Agonist Tirzepatide Is Associated With Fewer Asthma Exacerbations in Adults With Obesity
Year: 2026
Type: article
Abstract: Summary Tirzepatide use was associated with fewer asthma exacerbations in obese adults without prior exacerbations. Findings are limited to a selective asthma population and require validation in broader cohorts.
Source: Clinical & Experimental Allergy
DOI: 10.1111/cea.70245
Institutions: Howard University, University of Maryland, Baltimore
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7130420230
